Imagine being able to see the electrical currents of a beating heart in 3D without ever having to put a camera or wire inside the patient. This technology takes simple skin-surface heart readings and turns them into a virtual map that doctors can explore using VR goggles. It's like moving from a flat 2D sketch to a full 3D GPS map of the heart's electrical system.
Cardiac arrhythmia diagnosis currently relies on invasive imaging and costly procedures that require long hospital stays. There is a need for a fast, non-invasive, and radiation-free way to map heart activity.
A hardware-independent software platform that creates 3D cardiac activation maps from ECG signals, viewable via VR, AR, and holographic projections.
If you are a digital health provider dealing with the high cost of invasive cardiac imaging — this project developed a hardware-independent software platform that reconstructs 3D heart maps from ECG signals. This allows for radiation-free diagnostics and faster clinical adoption in hospitals.
If you are a clinic dealing with long hospital stays and complex diagnostic procedures for atrial fibrillation — this project developed a VR/AR visualization tool that makes the cardiac ablation process infinitely faster. It enables electrophysiologists to watch the electric impulse throughout the heart in 360 degrees.
If you are a hardware manufacturer dealing with the need to modernize existing ECG infrastructure — this project developed a software layer compatible with existing hospital ECG systems. This adds high-value 3D mapping capabilities to standard hardware without requiring new equipment purchases.
Based on available project data, specific pricing or cost per unit is not mentioned.
Yes, the project evolved into a hardware-independent software platform compatible with existing hospital ECG infrastructure to reduce deployment barriers.
Based on available project data, the project was developed by Spika Tech SL, but specific licensing terms are not provided.
The system is aligned with EU Medical Device Regulation (MDR 2017/745) and is undergoing CE certification as a Class IIb medical device.
CE certification is expected in July 2025.
It is designed as a software platform that is compatible with existing ECG infrastructure already present in hospitals.
The project is led by a single Spanish SME, Spika Tech SL, which holds 100% of the industry ratio. This lean structure suggests a highly focused development cycle where the SME controls the entire IP and technical roadmap from design to industrialization.
Contact Spika Tech SL regarding the Class IIb medical device certification
Contact us to explore licensing opportunities for the 3D cardiac mapping software.
